do glp 1 cause osteoporosis GLP-1 Medications Bone Loss? Evidence and Guidance – Bolt Pharmacy Effects of Glucagon-Like Peptide-1 receptor
Description
on your schedule Skip the unnecessary waiting room, see a board-certified physician now

Search string: (Glucagon-Like Peptide-1 Receptor Agonist* OR GLP-1-RA* OR GLP-1-R* OR GLP-1 Receptor Agonist* OR Liraglutide OR Semaglutide OR Tirzepatide OR Exenatide OR Exendin-4) AND (Stem Cells[Mesh] OR stem cell* OR stromal cell* OR adult progenitor cell* OR hASC OR hASCs OR ASC OR ASCs OR adipose-derived stem cell* OR ADSC* OR MSC OR mesenchymal stem cell* OR mesenchymal stromal cell* OR mesenchymal progenitor cell* OR bone-marrow derived mesenchymal stem cell* OR BD-MSC* OR umbilical cord tissue derived mesenchymal stem cell* OR UC-MSC*) The date of the search was June 30th, 2025
It works through AMP-activated protein kinase (AMPK) activation, which actually shares some mechanistic overlap with ketosis

Wegovy (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver This indication is approved based on improvement of MASH and liver scarring (fibrosis)

10.1371/journal.pone.0008334 PLo S One 41 LiuJ.CondeK.ZhangP.LilascharoenV.XuZ.LimB

The data for tirzepatide were too immature to support the analysis
